UNSPSC 51391733: Oxilofrine

This classification denotes an adrenergic agent with the molecular formula C10H15NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F49638UBDR, chemically known as (r*,s*)-4-hydroxy-alpha-(1-(methylamino)ethyl)benzyl alcohol but generally known as oxilofrine, which bears US NIH Compound Identifier 9701. European Medicines Agency schedules Oxilofrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09529MIG.

UNSPSC 51391733 Oxilofrine is a Commodity code covering pharmaceutical and medical substances used in emergency response and harm-reduction contexts. State and local governments procure under this code primarily naloxone (opioid-overdose reversal medication) and related drug deactivation systems for community health and public safety programs. Issuing bodies include county health departments and public health authorities managing overdose prevention and substance-use initiatives. The work centers on securing reliable pharmaceutical inventory for quarterly distribution to community health facilities, with vendors responsible for delivery logistics and compliance with E-Verify employment authorization and drug-free workplace certification.

Seminole County, Florida posted the most recent relevant opportunity: IFB 60459723LAS, a competitive invitation for bids closing July 26, 2023, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract carries a two-year initial term with one-year renewal option and includes requirements for workers' compensation, commercial general liability, and professional liability insurance. The bid process involved electronic submission through the county's e-Procurement Portal, with a three-month probationary termination clause and potential FEMA funding, introducing federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act. Recent activity appears concentrated in Florida, though the source provides only a single opportunity record and does not support broader geographic characterization.